COVID-19 vaccination and myasthenia gravis
- PMID: 37797299
- DOI: 10.1111/ene.16087
COVID-19 vaccination and myasthenia gravis
Comment on
-
Association between COVID-19 vaccination and myasthenia gravis: A population-based, nested case-control study.Eur J Neurol. 2023 Dec;30(12):3868-3876. doi: 10.1111/ene.16025. Epub 2023 Aug 13. Eur J Neurol. 2023. PMID: 37552795
-
COVID-19 vaccination and myasthenia gravis.Eur J Neurol. 2023 Dec;30(12):3988. doi: 10.1111/ene.16086. Epub 2023 Oct 5. Eur J Neurol. 2023. PMID: 37797298 No abstract available.
References
REFERENCES
-
- Kleebayoon A, Wiwanitkit V. COVID-19 vaccination and myasthenia gravis. Eur J Neurol. 2023;19.
-
- Arbel A, Bishara H, Barnett-Griness O, et al. Association between COVID-19 vaccination and myasthenia gravis: a population-based, nested case-control study. Eur J Neurol. 2023. doi:10.1111/ene.16025. Epub ahead of print.
-
- Hehir MK, Silvestri NJ. Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology. Neurol Clin. 2018;36(2):253-260. doi:10.1016/j.ncl.2018.01.002
-
- Gilhus NE, Nacu A, Andersen JB, Owe JF. Myasthenia gravis and risks for comorbidity. Eur J Neurol. 2015;22(1):17-23. doi:10.1111/ene.12599
-
- Rodrigues E, Umeh E, Uday A, Navaratnarajah N, Moy K. Incidence and prevalence of myasthenia gravis in the United States: a claims-based analysis (S19.007). Neurology. 2023;100(17 Suppl. 2):2994. doi:10.1212/WNL.0000000000202945
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical